Healthcare Generation AI provides opportunities to automate management processes, enhance diagnosis and personalize patient care. Partnerships and investments are driving growth with high interest from North American companies. This market is set for strong future expansion, particularly in clinical applications and treatments.
distribution
distribution
Partnerships and collaboration
Partnerships and collaboration
Healthcare Gen AI companies
Healthcare Gen AI companies
Dublin, October 1, 2025 (Globe Newswire) – “Generated AI in the Healthcare Market: Industry Trends and Global Forecast for 2035: Distribution by Purpose, Type of Delivery, Application Area, End Users, Key Geographic Regions, Key Players” report has been added to ResearchAndmarkets.com's offering.
The global generation AI for the healthcare market is currently valued at US$3.3 billion and is projected to reach US$39.8 billion by 2035, growing at a CAGR of 28% during the forecast period.
Generated AI is part of artificial intelligence that utilizes generative models to create data-driven outputs such as insights, images, videos, and other formats. In the healthcare sector, this technology is rapidly evolving and has the potential to transform patient care, research and treatment.
The healthcare industry is currently navigating a complex landscape characterized by many challenges, including inefficiencies in clinical workflows, escalating treatment costs, shortages in staff, and burnout of healthcare workers. Medscape's 2024 doctors' burnout and depression reported nearly 49% of doctors felt burnout, reporting administrative burden (62%) and long working hours (41%). Furthermore, traditional drug discovery methods remain time-intensive, without focusing on personalized therapeutic approaches. Furthermore, approximately 90% of drug candidates do not progress to the advanced clinical trial stage despite considerable time and financial investment. This high failure rate not only hinders innovation, but also strengthens financial stocks in the global healthcare system.
To address these challenges, several pharmaceutical and life science companies have shown increasing interest in investigating the adoption of generator AI. Furthermore, it is important to emphasize that generation AI in the healthcare industry has great potential to automate management processes to improve overall operational efficiency, increase diagnostic accuracy through advanced imaging, personalize patient engagement, and accelerate drug discovery and development.
In particular, implementation of AI generated by administrative tasks alone could generate approximately US$150 billion in annual savings across the healthcare sector. Furthermore, studies suggest that generative AI can reduce diagnostic errors by up to 85% and nursing overtime by 21%, potentially saving cost savings of nearly USD 469,000 over three years per hospital. However, as healthcare organizations integrate generated AI into their systems, it is essential to ensure the use of ethical AI, including data privacy, algorithm bias, and transparency, and establish a robust governance framework that addresses important concerns.
The story continues
In recent years, several pharmaceutical and healthcare companies have entered into strategic partnerships with a variety of AI companies to explore the application of generated AI in healthcare. At the same time, several generative AI developers have secured large amounts of funding to enhance the model capabilities of diverse medical applications. Given the growing interest of investors and the growing joint environment, healthcare market generation AI is experiencing sustainable growth over the next few years.
Generated AI used for clinical-based purposes may hold the largest share in the current market during forecast period
Based on purpose, the global market is divided into clinical and systems-based objectives. Of these types, the clinical-based objective segment holds the largest share of the market today. This can be attributed to a direct impact on patient care. These are because they help clinicians make informed decisions and increase adoption in hospitals and clinics.
Based on the type of offering, the Platform/Technology segment captures the majority of current market share
Based on product type, the global generation AI for the healthcare market is segmented into platforms/technology and services. Currently, the Platform/Technology segment holds the highest share of the overall market. However, it is important to note that the service segment is expected to grow at a relatively high CAGR during the forecast period.
The treatment segment could hold the largest share in healthcare market generation AI during forecast period
Based on application areas, the global generation AI for the healthcare market is divided into drug discovery and development, diagnostic, treatment, management tasks, and other application areas. Currently, the treatment segment leads the generation AI in the healthcare market. It is important to emphasize that this trend is unlikely to change in the future. This may be due to the fact that generative AI enhances therapeutic efficacy and patient care, reduces management burden, and promotes sustained growth of clinical applications.
Generating the healthcare market for healthcare providers AI could grow at a relatively fast pace during forecast periods
Based on end users, the global generation AI for the healthcare market is split into pharmaceutical and life science companies, healthcare providers and other end users. Currently, the market is dominated by revenue generated through systems intended for healthcare providers to use. Furthermore, this market trend is unlikely to change in the future due to the broader applicability of GEN AI solutions, including enhanced patient care, increased operational efficiency, data-driven insights, and the potential for cost savings.
North America holds the largest share of the market
Based on the main geographical region, the market is divided into Europe, Asia-Pacific, the Middle East, North Africa and Latin America. In the current scenario, North America could potentially gain the largest market share. Furthermore, it is worth highlighting that the Asia-Pacific region is expected to grow at a relatively high CAGR during the forecast period.
Generation AI in the healthcare market: key insights
Over 45% of companies in the healthcare industry engaged in providing generation AI solutions are medium-sized companies. Of these, 79% of companies are headquartered in North America.
>85% of companies offer GEN AI technology/platforms to streamline a variety of healthcare processes. Of these, 27% of GEN AI companies meet the evolving needs of both healthcare providers and P/B companies.
This growing interest in the domain is reflected in the increased number of partnership activities. In particular, nearly 90% of transactions have been in ink over the past two years.
Based on our analysis, we expect buyers to have very high negotiation power in the generation AI of health markets. The initiatives adopted should be evaluated carefully, taking into account the potential for future market dynamics.
Healthcare management burden, increased funding, investments, and advances in AI and ML are likely to drive the GEN AI market in healthcare, and will grow steadily in the near future.
The Technology/Platform segment controls the current market with nearly 75% of the market share. In particular, the generation AI for the healthcare market is expected to grow at a favorable growth rate (CAGR of 28%) until 2035.
Generation AI in the healthcare market: Research report
Generated AI in the Healthcare Provider Landscape: The report features a list of Generated AI for healthcare providers engaged in this domain.
Companies' Competitiveness Analysis: An insightful competitiveness analysis of healthcare provider-generated AI based on a variety of related parameters, such as (a) company strength and (b) service portfolio strength.
Company Profile: A comprehensive profile of key industry players in AI, featuring (a) company overview, (b) financial information (where available), (c) health portfolio generation AI, (d) recent developments, (e) healthcare domain generation AI, (e) healthcare domain generation, AI, (a) forward-looking statement information.
Partnerships and Collaboration: (a) Year of Partnership, (b) Type of Partnership, (c) Type of Partnership, (d) Purpose of Partnership, (e) Geography, (e) Geography, (g) Most Active Player (g) Most Active Player (g) (g) (g) (g) (g) (g) (g) (g) (g) (g) (g) (g) (g) (g) (g) (g) (g) For Partnership (c) Detailed Analysis of Partnership: Partnership: Detailed Analysis of Partnership.
Generated AI in Healthcare Use Cases: A detailed case study of Generated AI use cases in Healthcare. It presents information about the collaborations engraved among the various generation AI companies in healthcare. Each use case provides information on a variety of parameters, including (a) an overview of the company involved, (b) a business needs (c) details of the goals achieved, and (d) a solution provided.
Healthcare Generation AI: Use Cases
Use Case 1: Nvidia and Genentech Collaboration
Use Case 2: Collaboration between Insilico Medicine and Inimmune
Use Case 3: Openai and Moderna collaboration
Use Case 4: Amazon Web Services and Pfizer Collaboration
Use Case 5: Collaboration between Suki and Ascension St. Thomas
Use Case 6: Collaboration between Abridge and Emory Healthcare
Use Case 7: Collaboration between Google and China Medical University Hospital
The healthcare market generation AI players featured in the report are:
Amazon Web Services
C3 AI
Excientia
Google
Hummer
IBM
iktos
Leewewhertz
Medical IP
Microsoft
nvidia
Openai
Oracle
Phamax
Syntegra
Report scope:
the purpose
Clinical-based objectives
System-based objectives
Types of Offerings
Technology/Platform
service
Application Area
End User
Major Geographical Regions
North American market
European markets
Germany
UK
France
Spain
Switzerland
Netherlands
Remains of Europe
Asia Pacific Market
China
Japan
South Korea
Singapore
India
Remains of the Asia Pacific Region
Middle East and North African Markets
Latin American market
Brazil
Latin America Remains
Additional benefits
Free PPT Insights Pack
Free Excel Data Pack for all the analysis modules in the report
15% Free Content Customization
A detailed report walkthrough session with the research team
Free update reports if the report is 6-12 months or older
For more information about this report, please visit: https://www.researchandmarkets.com/r/uildhb
About ResearchAndmarkets.com ResearchAndmarkets.com is the world's leading source of international market research reports and market data. Provides the latest data on international and regional markets, major industries, top companies, new products and latest trends.
Attachments
Contact: Contact: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com est office hours for call call 1-917-300-0470 for can free call call for gmt office hours call +353-1-416-8900
